Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?
Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?
复制标题
DOI:
10.1016/j.ygyno.2016.08.235
复制
发表时间:
2016-11-01
影响因子:
4.7
通讯作者:
Donovan, Heidi S.
中科院分区:
文献类型:
--
作者:
Hay, Casey M.;Courtney-Brooks, Madeleine;Donovan, Heidi S.
Objective. We sought to compare symptoms identified as a priority by patients with recurrent ovarian cancer to symptoms most frequently documented by their clinicians, and examine the association between clinician documentation of symptoms and subsequent clinical intervention.Methods. Single-institution, retrospective chart review of patients enrolled in WRITE Symptoms Study (GOG 259), a randomized controlled trial of internet-based recurrent ovarian cancer symptom management. As part of the trial, women completed the Symptom Representation Questionnaire for 28 symptoms and selected 3 priority symptoms (PS). We compared patient-reported PS to clinician documentation of symptoms and interventions over the time period corresponding to study enrollment.Results. At least one PS was documented in 92% of patients. Of 150 PS reported by patients, 53% were never documented by clinicians; these symptoms tended to be less directly related to disease or treatment status. Symptoms not identified by patients as PS were frequently documented by clinicians; these symptoms tended to relate to physiologic effects of disease and treatment toxicity. 58% of patients had at least one PS intervention. PS intervened for were documented at 2.58 visits vs 0.50 visits for PS not receiving intervention (p